Found: 5
Select item for more details and to access through your institution.
ISL1 predicts poor outcomes for patients with gastric cancer and drives tumor progression through binding to the ZEB1 promoter together with SETD7.
- Published in:
- Cell Death & Disease, 2019, v. 10, n. 2, p. 1, doi. 10.1038/s41419-018-1278-2
- By:
- Publication type:
- Article
MicroRNA-1 acts as a tumor suppressor microRNA by inhibiting angiogenesis-related growth factors in human gastric cancer.
- Published in:
- Gastric Cancer, 2018, v. 21, n. 1, p. 41, doi. 10.1007/s10120-017-0721-x
- By:
- Publication type:
- Article
The novel lncRNA p4516 acts as a prognostic biomarker promoting gastric cancer cell proliferation and metastasis.
- Published in:
- Cancer Management & Research, 2019, v. 11, p. 5375, doi. 10.2147/CMAR.S201793
- By:
- Publication type:
- Article
Higher autocrine motility factor/glucose-6-phosphate isomerase expression is associated with tumorigenesis and poorer prognosis in gastric cancer.
- Published in:
- Cancer Management & Research, 2018, v. 10, p. 4969, doi. 10.2147/CMAR.S177441
- By:
- Publication type:
- Article
LAPTM4B-35, a Cancer-Related Gene, Is Associated with Poor Prognosis in TNM Stages I-III Gastric Cancer Patients.
- Published in:
- PLoS ONE, 2015, v. 10, n. 4, p. 1, doi. 10.1371/journal.pone.0121559
- By:
- Publication type:
- Article